Explained: Being ready with Oxford University vaccine before trial ends
Serum Institute of India, Pune, will start manufacturing the vaccine the moment the Phase-3 trial begins. The company is confident
Read MoreSerum Institute of India, Pune, will start manufacturing the vaccine the moment the Phase-3 trial begins. The company is confident
Read MoreBy the end of April, 263 people in South Korea who had recovered from COVID-19 had again tested positive for
Read MoreA ribonucleoside analog (β-D-N4-hydroxycytidine or NHC) that was previously shown to be effective against influenza and Ebola is also potent
Read MoreTedros and others caution that using BCG vaccine on health-care workers for COVID-19 should be only after safety and efficacy
Read MoreTreating severe COVID-19 patients with the antiviral drug remdesivir does not quicken recovery, the first randomised, placebo-controlled, double-blind trial found.
Read MoreNIBMG scientists have analysed 3,669 whole genome sequence data of novel coronavirus from across the world and found 10 types
Read MoreAll previous influenza pandemics — 1918 Spanish flu, 1957 Asian flu, 1968 Hong Kong influenza, and 2009 H1N1 — came
Read MoreIt took just 12 days for novel coronavirus cases to double to two million and another 12 days to cross
Read MoreLungs are just the ground zero for the virus while the novel coronavirus spreads its lethal tentacles to multiple organs
Read MoreResearchers have found that sewage surveillance can help in understanding the circulation of novel coronavirus (SARS-CoV-2) in the community. Sewage
Read MoreWhile acknowledging that India was “quick to close its international borders and enforce an immediate lockdown”, the editorial published in
Read MoreSymbolic gestures such as clapping hands and lighting candles in recognition of healthcare workers’ selfless service during these trying times
Read MoreThe Oxford University team that uses a recombinant viral vector vaccine that uses a chimpanzee adenovirus vaccine vector (ChAdOx1) that
Read More